About
Dr Uazman Alam is a Reader in Cardiovascular and Metabolic Medicine and Honorary Consultant Physician in Endocrinology and Diabetes at the University of Liverpool, where his clinical academic career bridges translational research and specialist diabetes care.
He read Medical Science (BSc) at the University of St Andrews before completing his MBChB and MPHe at the University of Manchester in 2005. His interest in diabetic complications began even earlier, as a fourth-year medical student studying peripheral nerve histology in experimental models of diabetic neuropathy. Before entering Higher Specialist Training in Endocrinology and Diabetes, he completed a PhD at the University of Manchester (2014) investigating the role of vitamin D in diabetic neuropathy. Working within major NIH- and JDRF-funded programmes during this period, he helped establish novel surrogate markers of small-fibre neuropathy including the application of corneal confocal microscopy with findings published in leading journals such as Diabetes and Diabetes Care.
He joined the University of Liverpool in 2017 as Senior Clinical Lecturer and Honorary Consultant Physician in Endocrinology and Diabetes, progressing to his current role as Reader. He is a Member of the Royal College of Physicians, currently serves on the executive committee of Neurodiab and Diabetes/Endocrine Research Lead for the NW Coast Clinical Research Network. He is Associate Editor for Clinical Medicine (Royal College of Physicians) and Topic Editor for Clinical Therapeutics; reviews regularly for journals including the New England Journal of Medicine, Diabetes Care, Diabetes, Obesity and Metabolism, and Diabetic Medicine; and is an external post-submission grant reviewer for the National Institute for Health and Care Research (NIHR).
Dr Alam's clinical and research expertise centres on the pathogenesis, assessment, prevention, and treatment of diabetic neuropathy and neuropathic pain, with complementary interests in diabetic retinopathy, obesity, chronic pain syndromes, and cardiovascular disease, extending more recently to ethnic disparities in cardiometabolic risk and the pain mechanisms of Long COVID. He has authored more than 200 PubMed-indexed publications with his work widely cited internationally, and presents regularly at national and international scientific meetings, including as a keynote speaker at Neurodiab 2025. His development of the EYE-SCREEN-4-DPN diabetic neuropathy screening test attracted national media coverage, including the BBC and national press.
His current research programme at the University of Liverpool spans diabetes complications, obesity, cardiovascular and metabolic disease, and chronic pain syndromes, funded by Diabetes UK, the Medical Research Council, the Pain Relief Foundation, the Department of Health and Social Care, and the Sir Jules Thorn Charitable Trust. He collaborates with industry,and has established partnerships with computer scientists, engineers, and data scientists to develop artificial intelligence-enabled approaches for the detection, risk stratification, and management of diabetes-related complications and cardiovascular disease, thus supporting the translation of digital health innovation into clinical practice.